Joel Haspel Director Strategy & Business Development EMEA, Oracle Health Sciences Joel leads the overall healthcare strategy and business development in EMEA, working across the Oracle Health Sciences Global Business Unit strategy, alliance, sales, consulting and solution consulting teams as well as the extended technology, applications and Industry Business Unit groups. Leveraging his 25 years [...]

Jeremy Haigh European Chief Operating Officer, Amgen Jeremy Haigh is responsible for Amgen’s Research & Development sites across Europe, the Middle East and Africa (EMEA), and for Global Development staff located in the region. He is a director of Amgen Limited, BioVex Limited, and the recently acquired Amgen Research (Munich) GmbH, a member of the [...]

Michel Goldman Executive Director, IMI Michel Goldman is the chief executive responsible for the management of IMI in accordance with the decisions of the Governing Board. He is supported by the staff of the Executive Office. As the Executive Director of IMI, he builds and promotes networks of innovation, in close collaboration with all stakeholders [...]

Sarah Garner Associate Director, Research and Development, National Institutes of Clinical Excellence Dr Sarah Garner PhD, BPharm is a pharmacist specialising in Health Technology Assessment (HTA). Sarah is the Associate Director for R&D at the UK’s National Institute for Health and Clinical Excellence (NICE) and is responsible for the planning and delivery of NICE’s R&D [...]

George Freeman Parliamentary Under Secretary of State for Life Sciences, UK Government George was elected to Parliament in May 2010 after a 15 year career in and around the Cambridge cluster supporting high growth businesses. George won the 2010 election for the new constituency of Mid Norfolk, with a majority of 14,000, after an innovative [...]

Pat Furlong Founding President and CEO, Parent Project Muscular Dystrophy Pat Furlong is the Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest nonprofit organization in the United States solely focused on Duchenne muscular dystrophy (Duchenne). Its mission is to improve the treatment, quality of life, and long-term outlook for all individuals [...]

Gary Finnegan Editorial Consultant, Moderator Gary Finnegan is an award-winning journalist, editor and author, with a particular interest in health, research and innovation policy. He has written and edited a range of magazines, newspapers and websites, including EurActiv, where he was science and health section editor. Gary has also written extensively for the pharmaceutical, vaccine [...]

Laura Jean Esserman, MD, MBA Director, Carol Franc Buck Breast Care Center (I-Spy) Professor of Surgery and Radiology, UCSF University of California, San Francisco Dr. Esserman is a surgeon and breast cancer oncology specialist, and is the Director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco (UCSF). In [...]

Hans-Georg Eichler Senior Medical Officer, EMA Hans-Georg Eichler, M.D., M.Sc., is the Senior Medical Officer at the European Medicines Agency in London, United Kingdom, where he is responsible for coordinating activities between the Agency’s scientific committees and giving advice on scientific and public health issues. From January until December 2011, Dr. Eichler was the Robert [...]

John Crawford Healthcare Industry Leader, IBM Europe John is jointly responsible for IBM’s Healthcare business in Europe, the Middle East and Africa. He is a member of several healthcare IT industry groups, including COCIR, Continua Health Alliance and Intellect . He represents IBM on the industry Team Steering Group of epSOS, an EU project to [...]